From Casetext: Smarter Legal Research

In re Lorazepam Clorazepate Antitrust Litigation

United States District Court, D. Columbia
Jan 31, 2002
CASE No. MDL 1290, Misc. No. 99-276 (TFH/JMF) CASE No. 1:99-CV-00790, CONSOLIDATED WITH, CASE No. 99 C2228 (D.D.C. Jan. 31, 2002)

Opinion

CASE No. MDL 1290, Misc. No. 99-276 (TFH/JMF) CASE No. 1:99-CV-00790, CONSOLIDATED WITH, CASE No. 99 C2228

January 31, 2002


ORDER


WHEREAS the Court having reviewed and considered Class Plaintiffs' Motion for Leave to File their Reply Memorandum In Support of Motion to Quash Subpoenas to Absent Class Memebers Under Seal,

IT IS HEREBY ORDERED that:

Class Plaintiffs' Motion for Leave to File Under Seal is granted and Class Plaintiffs are given permission to file their Reply Memorandum In Support of Motion to Quash Subpoenas to Absent Class Members under seal.


Summaries of

In re Lorazepam Clorazepate Antitrust Litigation

United States District Court, D. Columbia
Jan 31, 2002
CASE No. MDL 1290, Misc. No. 99-276 (TFH/JMF) CASE No. 1:99-CV-00790, CONSOLIDATED WITH, CASE No. 99 C2228 (D.D.C. Jan. 31, 2002)
Case details for

In re Lorazepam Clorazepate Antitrust Litigation

Case Details

Full title:IN RE: LORAZEPAM AND CLORAZEPATE ANTITRUST LITIGATION ADVOCATE HEALTH…

Court:United States District Court, D. Columbia

Date published: Jan 31, 2002

Citations

CASE No. MDL 1290, Misc. No. 99-276 (TFH/JMF) CASE No. 1:99-CV-00790, CONSOLIDATED WITH, CASE No. 99 C2228 (D.D.C. Jan. 31, 2002)